Technical Analysis for SCPH - scPharmaceuticals Inc.

Grade Last Price % Change Price Change
F 4.07 -1.93% -0.08
SCPH closed down 1.93 percent on Friday, November 1, 2024, on 55 percent of normal volume.
Earnings due: Nov 6
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Fell Below 20 DMA Bearish -1.93%
Doji - Bearish? Reversal -8.74%
Up 3 Days in a Row Strength -8.74%
Up 4 Days in a Row Strength -8.74%
20 DMA Support Bullish -8.13%
Up 3 Days in a Row Strength -8.13%
Crossed Above 20 DMA Bullish -6.86%
20 DMA Resistance Bearish -3.10%
Inside Day Range Contraction -3.10%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 16 hours ago
Fell Below Previous Day's Low about 16 hours ago
Down 2 % about 16 hours ago
Down 1% about 16 hours ago
Possible NR7 about 16 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

scPharmaceuticals Inc. Description

ScPharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip. The sc2Wear Infusor includes features, such as two-component design, automated safety features and micropiston pump technology. Its pipeline includes product timelines for preclinical, through regulatory approval. Its products will be administered subcutaneously through the sc2Wear Infusor. Its lead products are subcutaneous formulations of furosemide (parenteral diuretic in treating heart failure) and ceftriaxone (parenteral antibiotic outside the hospital setting). Its furosemide formulation has been optimized for use with the sc2Wear Infusor. Its pipeline also includes Ertapenem for subcutaneous delivery.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Drugs Medication Pharmaceutical Products Chemical Compounds Antibiotics Heart Failure Chloroarenes Injection Intravenous Fluids Intravenous Therapy

Is SCPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.71
52 Week Low 3.24
Average Volume 268,941
200-Day Moving Average 4.78
50-Day Moving Average 4.68
20-Day Moving Average 4.26
10-Day Moving Average 4.31
Average True Range 0.25
RSI (14) 39.02
ADX 23.2
+DI 15.76
-DI 25.42
Chandelier Exit (Long, 3 ATRs) 3.84
Chandelier Exit (Short, 3 ATRs) 4.57
Upper Bollinger Bands 4.59
Lower Bollinger Band 3.92
Percent B (%b) 0.22
BandWidth 15.84
MACD Line -0.10
MACD Signal Line -0.11
MACD Histogram 0.0085
Fundamentals Value
Market Cap 145.95 Million
Num Shares 35.9 Million
EPS -1.36
Price-to-Earnings (P/E) Ratio -2.99
Price-to-Sales 25.73
Price-to-Book 3.93
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.40
Resistance 3 (R3) 4.43 4.35 4.35
Resistance 2 (R2) 4.35 4.27 4.34 4.33
Resistance 1 (R1) 4.21 4.21 4.17 4.18 4.31
Pivot Point 4.13 4.13 4.11 4.12 4.13
Support 1 (S1) 3.99 4.05 3.95 3.96 3.83
Support 2 (S2) 3.91 3.99 3.90 3.81
Support 3 (S3) 3.77 3.91 3.80
Support 4 (S4) 3.74